[HTML][HTML] Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

…, H Bandos, E Senkus, JM Suga… - … England Journal of …, 2021 - Mass Medical Soc
Background Poly(adenosine diphosphate–ribose) polymerase inhibitors target cancers with
defects in homologous recombination repair by synthetic lethality. New therapies are …

[HTML][HTML] Functional near-infrared spectroscopy and its clinical application in the field of neuroscience: advances and future directions

WL Chen, J Wagner, N Heugel, J Sugar… - Frontiers in …, 2020 - frontiersin.org
Similar to functional magnetic resonance imaging (fMRI), functional near-infrared spectroscopy
(fNIRS) detects the changes of hemoglobin species inside the brain, but via differences …

Adjuvant palbociclib for early breast cancer: the PALLAS trial results (ABCSG-42/AFT-05/BIG-14-03)

…, G Pfeiler, KD Miller, M Colleoni, JM Suga… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Palbociclib is a cyclin-dependent kinase 4 and 6 inhibitor approved for advanced
breast cancer. In the adjuvant setting, the potential value of adding palbociclib to endocrine …

[HTML][HTML] Nivolumab is effective in mismatch repair–deficient noncolorectal cancers: Results from arm Z1D—A subprotocol of the NCI-MATCH (EAY131) study

…, SR Hamilton, N Bahary, JM Suga… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE The National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
trial, the largest national precision oncology study to date (> 1,100 sites) of patients with …

Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin.

…, H Masuzaki, K Hosoda, M Aizawa-Abe, J Suga… - Diabetes, 1999 - Am Diabetes Assoc
Excess of body fat, or obesity, is a major health problem and confers a higher risk of cardiovascular
and metabolic disorders such as diabetes, hypertension, and coronary heart disease…

Haematogenous metastastic patterns in colonic carcinoma: an analysis of 1541 necropsies

…, MJ Lopez, RI Shaw‐Dunn, J Sugar… - The Journal of …, 1986 - Wiley Online Library
The sequence of events in haematogenous metastasis from colonic carcinoma was analysed,
using 1541 necropsy reports from 16 centres. The findings are consistent with the cascade …

Assessment of treatment with sorafenib plus doxorubicin vs sorafenib alone in patients with advanced hepatocellular carcinoma: phase 3 CALGB 80802 randomized …

…, J Balletti, AB El-Khoueiry, JJ Harding, JM Suga… - JAMA …, 2019 - jamanetwork.com
Importance Previous communication has reported significant improvement in overall survival
(OS) when using doxorubicin plus sorafenib in the treatment of advanced hepatocellular …

La-and Mn-doped cobalt spinel oxygen evolution catalyst for proton exchange membrane electrolysis

L Chong, G Gao, J Wen, H Li, H Xu, Z Green, JD Sugar… - Science, 2023 - science.org
Discovery of earth-abundant electrocatalysts to replace iridium for the oxygen evolution
reaction (OER) in a proton exchange membrane water electrolyzer (PEMWE) represents a …

[HTML][HTML] TP53 gain-of-function and non–gain-of-function mutations are differentially associated with sidedness-dependent prognosis in metastatic colorectal cancer

…, A Arora, T Sundaresan, JM Suga… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
PURPOSE To examine the association of gain-of-function (GOF) and non–gain-of-function (non-GOF)
TP53 mutations with prognosis of metastatic right-sided (RCC) versus left-sided …

S1417CD: a prospective multicenter cooperative group-led study of financial hardship in metastatic colorectal cancer patients

…, JM Unger, AK Darke, JM Suga… - JNCI: Journal of the …, 2022 - academic.oup.com
Background Financial toxicity is a growing problem in oncology, but no prior studies have
prospectively measured the financial impact of cancer treatment in a diverse national cohort of …